Showing 1 - 10 of 43
Persistent link: https://www.econbiz.de/10009696071
This chapter presents MAMS (Maquette for MDG Simulations), a recursive-dynamic CGE model developed at the World Bank for analysis of medium- to long-run country strategies for low- and middle-income countries, including strategies aimed at improving MDG (Millennium Development Goals) outcomes....
Persistent link: https://www.econbiz.de/10014025287
This chapter presents MAMS (Maquette for MDG Simulations), a recursive-dynamic CGE model developed at the World Bank for analysis of medium- to long-run country strategies for low- and middle-income countries, including strategies aimed at improving MDG (Millennium Development Goals) outcomes....
Persistent link: https://www.econbiz.de/10010719528
Persistent link: https://www.econbiz.de/10001801341
Persistent link: https://www.econbiz.de/10003977705
Persistent link: https://www.econbiz.de/10011414939
Persistent link: https://www.econbiz.de/10012130218
We estimate the Marginal Cost of Public Funds for Argentina using a Computable General Equilibrium (CGE) model, assessing the sensitivity of the results to the existence of alternative regulatory regimes (price-cap and cost-plus) for public utilities subject to regulation. The estimates are in...
Persistent link: https://www.econbiz.de/10009653921
This article provides a synopsis of the new dynamics of the global biopharma industry. The emergence of global generics companies with capabilities approximating those of 'big pharma' has accelerated the blurring of boundaries between the innovator and generics sectors. Biotechnology-based...
Persistent link: https://www.econbiz.de/10009483744
Persistent link: https://www.econbiz.de/10003732369